Literature DB >> 21722261

Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.

M L Mezzatesta1, M M D'Andrea, R Migliavacca, T Giani, F Gona, E Nucleo, G Fugazza, L Pagani, G M Rossolini, S Stefani.   

Abstract

This study was aimed at tracing the molecular characteristics of carbapenem-resistant Acinetobacter baumannii (CRAB) clinical isolates in Italy with both pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Two hundred and two CRAB isolates were collected during 2004-2009, in two different surveillance periods, from 22 Italian hospitals that were representative for both distribution and infection. PFGE was performed, and the MLST scheme used was based on the gene sequence as published on the MLST Pasteur website http://www.pasteur.fr/mlst. Representatives of the major European clones I (RUH 875) and II (RUH 134) were used as controls. The two groups of isolates were characterized for their carbapenem resistance genes: 154 of 202 carried bla(OXA-58) alone, 21 of 202 also carried bla(OXA-23) , and 27 of 202 carried bla(OXA-23) alone. No isolates were positive for bla(OXA-24) . Genotype analysis of all isolates identified four distinct patterns by PFGE, which correlated with four distinct sequence types (STs) by MLST. The distribution of these four clusters in Italy confirmed the propensity of A. baumannii for nosocomial cross-transmission in a vast geographical area. We observed that clones A and B had similarities with European clone II and I respectively. By MLST, clone A was ST2, like European clone II, and clone B was ST1, like European clone I. PFGE and MLST showed the same discriminatory power and reproducibility. In addition, the two methods were concordant in defining CRAB Italian clones and in correlating them with the two pan-European clones.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722261     DOI: 10.1111/j.1469-0691.2011.03527.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  17 in total

1.  Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii.

Authors:  Laurent Poirel; Rémy A Bonnin; Anne Boulanger; Jacques Schrenzel; Martin Kaase; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination.

Authors:  Chunmei Ying; Yongli Li; Yaping Wang; Bing Zheng; Chengde Yang
Journal:  J Antibiot (Tokyo)       Date:  2015-04-15       Impact factor: 2.649

3.  Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump.

Authors:  Xinlong He; Feng Lu; Fenglai Yuan; Donglin Jiang; Peng Zhao; Jie Zhu; Huali Cheng; Jun Cao; Guozhong Lu
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

4.  Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II.

Authors:  Fabrizia Minandri; Silvia D'Arezzo; Luísa C S Antunes; Christine Pourcel; Luigi Principe; Nicola Petrosillo; Paolo Visca
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

5.  The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China.

Authors:  X Zhen; Y Chen; X Hu; P Dong; S Gu; Y Y Sheng; H Dong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-23       Impact factor: 3.267

6.  Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey.

Authors:  Luigi Principe; Aurora Piazza; Tommaso Giani; Silvia Bracco; Maria Sofia Caltagirone; Fabio Arena; Elisabetta Nucleo; Federica Tammaro; Gian Maria Rossolini; Laura Pagani; Francesco Luzzaro
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

7.  First detection of OXA-24 carbapenemase-producing Acinetobacter baumannii isolates in Bulgaria.

Authors:  Bozhana Todorova; Tzvetan Velinov; Ivan Ivanov; Elina Dobreva; Todor Kantardjiev
Journal:  World J Microbiol Biotechnol       Date:  2013-11-28       Impact factor: 3.312

8.  RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.

Authors:  Eun-Jeong Yoon; Patrice Courvalin; Catherine Grillot-Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

9.  Molecular Characterization of Carbapenem Resistant Isolates of Acinetobacter baumannii in An Intensive Care Unit of A Tertiary Care Centre at Central India.

Authors:  Atul Khajuria; Ashok Kumar Praharaj; Mahadevan Kumar; Naveen Grover
Journal:  J Clin Diagn Res       Date:  2014-05-15

10.  Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain.

Authors:  Noraida Mosqueda; Paula Espinal; Clara Cosgaya; Sergio Viota; Virginia Plasensia; Francisco Alvarez-Lerma; Milagro Montero; Julià Gómez; Juan Pablo Horcajada; Jordi Vila; Ignasi Roca
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.